Literature DB >> 11566551

Nitric oxide production in Caco-2 cells exposed to different inducers, inhibitors and natural toxins.

A L Vignoli1, R C Srivastava, A Stammati, L Turco, M Tanori, F Zucco.   

Abstract

The involvement of the NO pathway in several intestinal inflammatory diseases is under investigation. In vitro models may provide a useful approach to better characterise this pathway at the cellular level. For this purpose, we have used Caco-2 cells, which are able to spontaneously differentiate in long-term culture to small intestine enterocytes. The effect of different NO pathway inducers [gamma-interferon (IFN-gamma) and phorbol myristate acetate (PMA)] has been studied. Our results demonstrate that Caco-2 cells constitutively express NOS at very low levels, while the induction with PMA+IFN-gamma triggers the expression of the inducible isoform with a stronger effect starting from day 14 of differentiation. The use of specific inhibitors of gene expression, at transcriptional and translational level, suggests that new synthesis of iNOS mRNA is required, through direct activation of the gene or new synthesis of transcription-required factors, as indicated by CHX inhibition. The morphological alteration induced by PMA+IFN-gamma is reversed by iNOS inhibitor, suggesting that the NO pathway may be involved in the cytoskeletal alterations. The DSP toxins, OA and DTX-1, induce NO production at levels corresponding to their different toxicity, previously detected in Caco-2 cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566551     DOI: 10.1016/s0887-2333(01)00023-6

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  6 in total

1.  Development of Cell-Based Sentinels for Nitric Oxide: Ensuring Marker Expression and Unimodality.

Authors:  Ryan McKay; Pricila Hauk; David Quan; William E Bentley
Journal:  ACS Synth Biol       Date:  2018-07-09       Impact factor: 5.110

2.  Gut microbial transcytosis induced by tumor necrosis factor-like 1A-dependent activation of a myosin light chain kinase splice variant contributes to IBD.

Authors:  Yu-Chen Pai; Li-Ting Weng; Shu-Chen Wei; Li-Ling Wu; David Q Shih; Stephen R Targan; Jerrold R Turner; Linda Chia-Hui Yu
Journal:  J Crohns Colitis       Date:  2020-08-08       Impact factor: 9.071

3.  Experimental basis for the high oral toxicity of dinophysistoxin 1: a comparative study of DSP.

Authors:  Diego A Fernández; M Carmen Louzao; María Fraga; Natalia Vilariño; Mercedes R Vieytes; Luis M Botana
Journal:  Toxins (Basel)       Date:  2014-01-03       Impact factor: 4.546

4.  Uptake and Immunomodulatory Properties of Betanin, Vulgaxanthin I and Indicaxanthin towards Caco-2 Intestinal Cells.

Authors:  Yunqing Wang; Ganwarige Sumali N Fernando; Natalia N Sergeeva; Nikolaos Vagkidis; Victor Chechik; Thuy Do; Lisa J Marshall; Christine Boesch
Journal:  Antioxidants (Basel)       Date:  2022-08-22

5.  An In Vitro Model of Gastric Inflammation and Treatment with Cobalamin.

Authors:  T R Elliott; A L Guildford
Journal:  Int J Inflam       Date:  2017-06-06

6.  A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease.

Authors:  Ryan McKay; Monil Ghodasra; John Schardt; David Quan; Alex Eli Pottash; Wu Shang; Steven M Jay; Gregory F Payne; Matthew Wook Chang; John C March; William E Bentley
Journal:  Bioeng Transl Med       Date:  2018-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.